Immunohistochemical expression of stem cell markers CD133 and Oct-4 in cases of endometrial hyperplasia and endometrial carcinoma
Conclusion
A positive correlation between the markers CD133 and Oct4 and the tumor stage was observed, indicating that CD133 and Oct4 may be used as significant prognostic markers. Further studies with larger sample sizes and follow-up data of longer intervals are recommended.
Source: Egyptian Journal of Pathology - Category: Pathology Tags: Original Articles Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Cancer Therapy | Carcinoma | Egypt Health | Endometrial Cancer | Pathology | Stem Cell Therapy | Stem Cells | Study | Undifferentiated Carcinoma